Background and Aim: Standard surveillance methods for pharyngeal cancer have not been established. We conducted a randomized controlled trial to investigate the best sedation method for pharyngeal observation using transoral endoscopy.
INTRODUCTION

I
N MEN, HEAD and neck cancer (HNC) is the seventh most common cause of cancer death in developed countries and the fifth in less developed countries. 1 Although the age-standardized annual incidence of HNC among men is 13.3-17.4 per 100 000, individuals who drink, smoke, and have pharyngeal symptoms 2 and a history of esophageal cancer (EC) [3] [4] [5] [6] [7] have a much higher incidence. HNC is detected in 3.5-13% of patients with EC, [2] [3] [4] [8] [9] [10] which indicates the importance of surveillance. HNC is sometimes detected at an advanced stage 5, 11 and is the major cause of death for EC patients. Advanced-stage cancer requires invasive treatment such as surgical resection or chemoradiotherapy, and these treatments degrade quality of life. [12] [13] [14] [15] If cancers are detected at an early stage, implementation of minimally invasive treatment and better prognosis are expected. [16] [17] [18] Upper gastrointestinal endoscopy (UGIE) and narrow band imaging (NBI) has been reported to be useful for early detection of HNC, especially pharyngeal cancer (PC), [8] [9] [10] 19, 20 and it is currently considered the best modality for early detection of PC. For pharyngeal observation, patient cooperation is important because their vocalization can help to open the pyriform sinus and the space surrounding the uvula. To obtain patient cooperation, pharyngeal observation is sometimes conducted without sedation; however, it is not feasible for some patients because of the gag reflex and discomfort.
Transnasal endoscopy can suppress the gag reflex and may provide the ideal condition for pharyngeal observation. 21, 22 However transnasal endoscopy does not have a magnifying function and usually has lower resolution than transoral endoscopy. Considering that detailed examination with magnification is frequently required in esophageal cancer patients, 8 transoral endoscopy has some advantages for the surveillance of esophageal cancer patients.
Sedation using benzodiazepines can decrease the gag reflex and discomfort, and increase patient acceptance. However, sedation disturbs patient vocalization and observation of the pyriform sinus and the uvula. Indeed, a previous study failed to demonstrate any benefit from use of benzodiazepines for observation of the pyriform sinus. 20 Opioids are another option for UGIE, which can achieve conscious sedation. 23, 24 Using opioids, it is possible to obtain patient cooperation while reducing the gag reflex and discomfort. This drug may provide the best conditions for pharyngeal observation; however, no previous studies have evaluated the utility of this drug. Thus, we conducted a randomized controlled trial (RCT) to evaluate the efficacy of opioids for pharyngeal screening using transoral endoscopy.
METHODS
Study protocol
T HIS STUDY WAS designed as a RCT and was conducted at the Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan. The study protocol was approved by the ethics committee of our hospital, and was registered in the University Hospital Medical Network Clinical Trials Registry as number UMIN 000016722.
Patients undergoing surveillance or diagnostic examinations for EC were considered for enrollment. Inclusion criteria were: (i) patients with esophageal squamous cell carcinoma (ESCC) before or under treatment; or (ii) patients who had a history of ESCC. Patients were excluded if they had: (i) PC that was diagnosed before this study; (ii) bleeding tendency; or (iii) severe organ failure. Written informed consent was obtained from all patients before enrollment.
Randomization of the participants was carried out using a minimization method. A randomization table was prepared using Excel 2010 (Microsoft Corporation, Redmond, WA, USA). The participants were stratified according to their previous history of sedation for UGIE (previous use of sedation or no sedation). After stratification, participants were randomly allocated into each of three groups according to the sedation method (no sedation group, midazolam group, or pethidine group). The sequence was concealed from the endoscopists until UGIE was assigned.
Preparation and sedation for UGIE
Patients ingested a mixture consisting of a mucolytic agent (20 000 U pronase; Kaken Pharmaceutical, Tokyo, Japan), a defoaming agent (12 mg dimethylpolysiloxane syrup; Kissei Pharmaceutical, Matsumoto, Japan), and 1 g sodium bicarbonate diluted in 40 mL tap water before the examination. Subsequently, half of a mixture consisting of 2% lidocaine viscous solution (7 mL Xylocaine Viscous: AstraZeneca, Osaka, Japan) and 3 mL simple syrup (Nakakita Pharmaceutical, Tsushima, Japan) was ingested, and then the other half was ingested after retention in the throat for 1 min to ensure pharyngeal anesthesia. At the start of the procedure, patients were placed in the left lateral decubitus position, and UGIE was conducted without sedation or under conscious sedation with midazolam or pethidine hydrochloride.
In the midazolam group, patients were asked to keep their eyes open. Then midazolam was repeatedly given in 0.5-1.0-mg increments. UGIE was started immediately after the patients closed their eyes because this condition (Ramsay score 3) 25 was considered to be the best for pharyngeal observation. In the pethidine group, pethidine hydrochloride (35 mg) was given i.v. In the no sedation group, no anesthetic injection was given. In all groups, no anticholinergic agents were used.
Pharyngeal observation and monitoring
All procedures were carried out using magnifying endoscopes that were 10.2 mm in outer diameter (GIF-Q240Z or GIF-RQ260Z: Olympus, Tokyo, Japan) and a standard video endoscope system (EVIS LUCERA ELITE: Olympus) by six endoscopists (Y.Y., R.I., N.H., N.M., T.K., and T.A.).
Pharyngeal observation was carried out according to a protocol. The endoscopists started the observation from the pharyngeal portion of the tongue. In turn, they observed the uvula, the posterior wall of the oropharynx, the epiglottic vallecular, the right pyriform sinus and the left pyriform sinus (Fig. 1 ). Patients were requested to perform appropriate vocalizations during observation of the uvula and the pyriform sinuses. After observation of the five prescribed pharyngeal regions, the scope was gently inserted into the esophagus. After UGIE had been done, quality of endoscopic observation for seven sites in the five pharyngeal regions, namely: (i) uvula; (ii) posterior wall of the oropharynx; (iii) epiglottic vallecular; (iv) inner wall of right pyriform sinus; (v) inner wall of left pyriform sinus; (vi) outer wall of right pyriform sinus; and (vii) outer wall of left pyriform sinus was graded (0 = poor and 1 = good) by the endoscopists who carried out the procedure. Endoscopic images taken from an appropriate distance to observe surface vessels using an appropriate focus were graded as good. Images that were out of focus or were taken at an inappropriate distance for clear observation of the surface vessels were graded as poor. Thus, pharyngeal observation was evaluated using a seven-point scale. When abnormal mucosal areas were identified during standard protocols, we evaluated the areas on withdrawal of the endoscope by magnifying NBI. If dilated and tortuous intraepithelial papillary capillary loop (IPCL) patterns were observed, 8, 26 we defined the areas as abnormal lesions and took biopsies. Quality of endoscopic observation for seven sites in five pharyngeal regions was also evaluated after the procedure based on viewing endoscopic images by other endoscopists (second evaluators) who were blinded to the sedation method. Second evaluators evaluated all endoscopic images.
Blood pressure, heart rate and peripheral arterial oxygen saturation (SpO 2 ) were measured during pharyngeal observation. Pharyngeal observation time required for cancer screening on insertion of the endoscope was measured.
Histological evaluation
Biopsy specimens from abnormal mucosal areas with irregular IPCL were obtained using disposable forceps. All specimens were evaluated by experienced pathologists, who were blinded to the sedation methods. Histological observations were made according to the World Health Organization criteria. 27 
Discomfort during pharyngeal observation
A 100-mm visual analogue scale (VAS) consisting of a horizontal line 100 mm in length was used for measuring patient discomfort during pharyngeal observation (0 mm = painless and 100 mm = extremely painful). 28 Patients recorded the level of the experienced symptom after UGIE.
Endpoints
Primary endpoint was the total score of the five pharyngeal regions, which showed the efficacy of each sedation method. Digestive Endoscopy 2017; 29: 39-48 Sedation for pharyngeal observation 41
Secondary endpoints were: a proportion of the perfect score involving the seven-point scale; pharyngeal observation time; VAS score for discomfort during the pharyngeal observation; and change in vital signs.
Sample size
A preliminary pilot study was conducted to estimate the standard deviation (SD) of the total score of the five pharyngeal regions. In a pilot study, the total scores examined with no sedation, midazolam, and pethidine hydrochloride were 5.0, 4.0, and 6.0, respectively, with an SD of approximately 1.32. Bonferroni correction was used for multiple comparisons, and the study sample size was calculated at 111 patients to achieve an 80% power with two-sided a levels of 0.05/3 for the detection of any differences in the total score of the five pharyngeal regions between the three groups. The final sample required was 40/ group patients to accommodate an attrition rate of 10%.
Statistical analysis
Results are presented as the mean AE SD for continuous variables. 
RESULTS
Recruitment and participant flow B ETWEEN MARCH AND May 2015, 153 patients undergoing surveillance or diagnostic UGIE for EC were invited to participate in the present study. Of these, 28 declined, four could not participate because they had to drive a car after examination, and one had severe heart failure; thus, 33 patients were excluded from enrollment. A total of 120 patients were enrolled in this study, and they were randomized into three groups according to the sedation method used prior to their endoscopic examination. Of these, 41 were assigned to the no sedation group, 40 to the midazolam group, and 39 to the pethidine group (Fig. 2) .
Patient characteristics
There were no differences in clinical characteristics between the three groups ( Table 1 ). About half of the patients in each group had previously undergone sedation with midazolam. 
Pharyngeal observation score
Total scores for the five pharyngeal regions are shown in Table 2 and Fig. 3 . The pethidine group had a significantly higher score than the no sedation group (P = 0.0001) and the midazolam group (P < 0.0001). There was no significant difference in the scores between the no sedation group and the midazolam group (P = 0.18). Scores for the observation of the uvula, the epiglottic vallecular, and the pyriform sinus differed significantly between the three groups.
The pethidine group had a significantly higher proportion of patients with a perfect score than did the no sedation group (P = 0.0004) and the midazolam group (P < 0.0001; Fig. 4) .
In subgroup analyses, total scores for the no sedation group, the midazolam group and the pethidine group in patients who had experienced no previous sedation were 6.5, 5.7, and 6.9, respectively (P = 0.0004; Kruskal-Wallis test). The pethidine group had a significantly higher score than the midazolam group (P = 0.0002), but there was no significant difference between the pethidine group and the no sedation group (P = 0.08). Total scores of the no sedation group, the midazolam group and the pethidine group in patients who had previously undergone sedation were 4.9, 5.2, and 6.8, respectively (P = 0.0002; Kruskal-Wallis test). The 
pethidine group had a significantly higher score than the no sedation group (P = 0.0002) and the midazolam group (P = 0.0002). Total scores evaluated by the second evaluators who were blinded to the sedation methods were the same as those evaluated by the endoscopists who carried out the procedures (Table 3 ). The pethidine group had a significantly higher score than the no sedation group (P = 0.0023) and the midazolam group (P < 0.0001). There was no significant difference between the no sedation group and the midazolam group (P = 0.18). The correlation coefficient regarding the total score for the five pharyngeal regions showed a strong correlation between the endoscopists who carried out the procedure and the second evaluators (r = 0.76).
Other outcomes
Discomfort during pharyngeal observation score differed significantly (P < 0.0001; Kruskal-Wallis test). The score between the pethidine group and the no sedation group (P = 0.0004), and between the midazolam group and the no sedation group (P < 0.0001) also differed significantly. However, the score between the pethidine group and the midazolam group did not differ significantly (P = 0.21). Pharyngeal observation time was longest in the midazolam group (P < 0.0001; Kruskal-Wallis test; Table 2 ).
Adverse events in each group are detailed in Table 4 . In the midazolam group, decrease in SpO 2 and systolic blood pressure during the procedure was significantly greater than those in the no sedation group and in the pethidine group (P = 0.0001 and P < 0.0001, respectively).
Results of the biopsies are detailed in Table 5 . We detected 20 abnormal pharyngeal lesions and took biopsies. Histological examination of biopsies or endoscopic resection confirmed that 11 lesions were pharyngeal neoplasms. Nine lesions were located in the pyriform sinus, and two in the posterior wall of the oropharynx. There were no differences in detection rates for the pharyngeal neoplasms among the three groups (P = 0.89).
DISCUSSION
I
N THE PRESENT study, we demonstrated that pharyngeal observation with pethidine hydrochloride was superior to either midazolam or no sedation. The pethidine group had a significantly higher score for pharyngeal observation, and a higher proportion of patients with a perfect score than the other two groups. The discomfort score and adverse events for the pethidine group were no worse than for the other two groups.
Pethidine hydrochloride has two advantages regarding pharyngeal observation. First, it has been reported to reduce the gag and cough reflexes. 22, 29 The gag reflex is induced by touching the base of the tongue, soft palate, uvula or Figure 3 Total score for the seven sites in the five pharyngeal regions evaluated by the endoscopists who carried out the procedures. The score was significantly different (P < 0.0001; Kruskal-Wallis test), being significantly higher in the pethidine hydrochloride group than in the no sedation (P = 0.0001; Mann-Whitney U-test) and midazolam (P < 0.0001; Mann-Whitney U-test) groups. Figure 4 Perfect scores using the seven-point scale. Proportion of perfect scores was significantly different (P < 0.0001; chi-squared test), the score for the pethidine hydrochloride group being significantly higher than the score for the no sedation (P = 0.0004; Fisher's exact test) and the midazolam (P < 0.0001; Fisher's exact test) groups.
posterior pharyngeal wall. When the endoscope touches the oropharyngeal region, the glossopharyngeal nerve afferents are stimulated and the polysynaptic reflex is induced in the glossopharyngeal and trigeminal nerve efferents through the solitary nucleus and ambiguous nucleus of the medulla oblongata; this results in the gag reflex. 30, 31 Pethidine hydrochloride is considered to suppress the gag reflex or cough reflex by affecting opiate receptors and neurons in the medulla oblongata. 32 Second, pethidine hydrochloride achieves conscious sedation so that patients can vocalize during pharyngeal observation. Vocalization is an important technique that facilitates observation of the pharyngeal regions, 21, 33, 34 especially both pyriform sinuses. Considering that most Digestive Endoscopy 2017; 29: 39-48 Sedation for pharyngeal observation 45 hypopharyngeal cancers arise in the pyriform sinus, 35, 36 good visualization of the pyriform sinus is indispensable for early detection of PC.
Benzodiazepines such as midazolam are popular for UGIE, because they can reduce the gag reflex and discomfort during UGIE. In our study, midazolam reduced discomfort during pharyngeal observation relative to no sedation. However, midazolam did not improve pharyngeal observation. The midazolam group had a lower score in the uvula and the pyriform sinus. Usually these areas can be clearly observed during patient vocalization. A lower score in the midazolam group can be explained by the patient's inability to vocalize and reduced consciousness in this group.
Recently, transnasal endoscopy was reported to be useful for pharyngeal observation. 21, 22 In these studies, pharyngeal observation images by transnasal endoscopy were better than those by transoral endoscopy, and gag reflex and adverse events in transnasal endoscopy were lower than those in transoral endoscopy. However, in these studies, transoral endoscopy was carried out under no sedation or sedation with benzodiazepine drugs. As we showed, transoral endoscopy using pethidine hydrochloride achieved excellent pharyngeal observation and reduced gag reflex and adverse events. Besides, transoral endoscopy allows detailed examination of the esophagus 8 and the stomach, which is very important for the surveillance of esophageal cancer patients.
In the present study, we evaluated the quality of pharyngeal observation using our original scoring system. Currently, there is no standard scoring system for pharyngeal observation. In a previous study, Tsuji et al. 20 used their own scoring system, which consisted of 10 pharyngeal regions (right palatal arch, left palatal arch, right wall of the oropharynx, left wall of the oropharynx, posterior wall of the oropharynx, uvula, epiglottis, vocal cord, right pyriform sinus and left pyriform sinus). However, these 10 regions have greatly differing risks of cancer. For example, pyriform sinus has a much higher risk of cancer than the uvula or the epiglottis. Consequently, the score does not reflect the quality of pharyngeal observation for cancer detection. We considered the risk of cancer in each pharyngeal region and allocated points depending on the risk of cancer. In our scoring system, the pyriform sinuses had a much higher number of points than did the uvula or the epiglottis. Potentially, our scoring system correlates well with the quality of pharyngeal observation for cancer detection.
Even though we successfully revealed the usefulness of pethidine hydrochloride, there were several limitations to our study. First, it was a single-center and unblinded study. The scoring for pharyngeal observation may have been biased because the endoscopists knew to which sedation method the patient was allocated. To eliminate this bias, all endoscopic images were also evaluated by other endoscopists who were blinded to the sedation method. In the analysis by endoscopists who were blinded to the sedation method, pethidine hydrochloride was again confirmed to be the best method for pharyngeal observation and correlation of scores between blinded endoscopists and unblinded endoscopists were high.
Second, we defined the observation quality of the five pharyngeal regions as a primary outcome. We should have evaluated the cancer detection rate using the various sedation methods; however, such a study design was not feasible considering the low incidence of PC. 35, 37 In our original scoring system, we allocated scoring point taking the cancer risk in each pharyngeal region into consideration. Although we could not directly compare the cancer detection rates, our scoring system may be a good surrogate marker of cancer detection.
Third, all of the patients included in this study had present or past history of esophageal cancer. These patients may have different characteristics from the general population in terms of drinking or smoking habits. Therefore, general applicability of the results of this study should be confirmed in further studies.
In conclusion, we conducted the first RCT to compare sedation methods during pharyngeal observation using transoral endoscopy. Pethidine hydrochloride was found to be the best and safest sedation method for pharyngeal observation in esophageal cancer patients.
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